Cdrh gas chromatography-mass spectrometry (GC/MS) direct injection system and extended service warranty

Active Awarded Last action

Contract number
75F40123F80315
Awardee
Awarding agency
Obligated
$139,186

Award facts

Opportunity
  • 75F40123Q00164 Solicitation number
Contract value 88% obligated
$158,483.98 Current and potential, with all options
Completion date 61% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 $9,649
Other Administrative Action P00003 $0
Exercise an Option P00002 $9,649
Other Administrative Action P00001 $0
Original award $119,888

About this award

Agilent Technologies Inc. received a delivery order from the Food and Drug Administration's Center for Devices and Radiological Health (CDRH) on August 31, 2023, for a gas chromatography-mass spectrometry (GC/MS) direct injection system and extended service warranty. The contract, valued at $158,483.98 on a firm fixed-price basis, is scheduled for completion by November 15, 2028, and will be performed at the FDA's Silver Spring, Maryland facility. This delivery order is issued under Agilent's Multiple Award Schedule (MAS) contract with the federal government, which enables streamlined procurement of analytical instrumentation and related services across civilian agencies.

The award reflects the FDA's ongoing need for advanced analytical capabilities in support of its regulatory and testing operations. As a global leader in life sciences and diagnostics, Agilent routinely supplies sophisticated laboratory instruments including GC-MS systems, maintenance services, and scientific consumables to federal agencies without set-aside designations, competing effectively in full and open competition. This delivery order is part of the contractor's broader portfolio supporting federal agencies including the National Institutes of Health, Drug Enforcement Administration, Environmental Protection Agency, and Department of Defense through both prime contracts and indefinite delivery vehicles, including a significant $14.3 million Army Research, Development and Engineering Command contract extending through 2030.

Quick answers

Who was awarded contract 75F40123F80315?

75F40123F80315 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on August 31, 2023.

How much is contract 75F40123F80315 worth?

The government has obligated $139,186 on 75F40123F80315. Its current value, with exercised options, is $158,484.

Is contract 75F40123F80315 an order under another contract?

Yes. 75F40123F80315 is a delivery order under GS07F0564X, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40123F80315 competed?

The extent of competition for 75F40123F80315 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award